annual SGA:
$178.18M+$67.36M(+60.78%)Summary
- As of today (July 4, 2025), RXRX annual SGA is $178.18 million, with the most recent change of +$67.36 million (+60.78%) on December 31, 2024.
- During the last 3 years, RXRX annual SGA has risen by +$120.50 million (+208.91%).
- RXRX annual SGA is now at all-time high.
Performance
RXRX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$54.65M-$22.54M(-29.20%)Summary
- As of today (July 4, 2025), RXRX quarterly SGA is $54.65 million, with the most recent change of -$22.54 million (-29.20%) on March 31, 2025.
- Over the past year, RXRX quarterly SGA has increased by +$23.24 million (+74.00%).
- RXRX quarterly SGA is now -29.20% below its all-time high of $77.19 million, reached on December 31, 2024.
Performance
RXRX quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$5.47B-$574.70M(-11.73%)Summary
- As of today (July 4, 2025), RXRX TTM SGA is -$5.47 billion, with the most recent change of -$574.70 million (-11.73%) on March 31, 2025.
- Over the past year, RXRX TTM SGA has dropped by -$5.59 billion (-4686.23%).
- RXRX TTM SGA is now -2462.67% below its all-time high of -$213.60 million.
Performance
RXRX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
RXRX Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +60.8% | +74.0% | -4686.2% |
| 3 y3 years | +208.9% | +159.3% | -7940.1% |
| 5 y5 years | +840.2% | +882.7% | -10000.0% |
RXRX Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +208.9% | -29.2% | +180.4% | -219.6% | at low |
| 5 y | 5-year | at high | +840.2% | -29.2% | +959.3% | -2462.7% | at low |
| alltime | all time | at high | +840.2% | -29.2% | +959.3% | -2462.7% | at low |
RXRX Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $54.65M(-29.2%) | $201.43M(+13.0%) |
| Dec 2024 | $178.18M(+60.8%) | $77.19M(+104.4%) | $178.18M(+35.5%) |
| Sep 2024 | - | $37.76M(+18.6%) | $131.46M(+7.0%) |
| Jun 2024 | - | $31.83M(+1.4%) | $122.90M(+3.0%) |
| Mar 2024 | - | $31.41M(+3.1%) | $119.36M(+7.7%) |
| Dec 2023 | $110.82M(+35.8%) | $30.46M(+4.3%) | $110.82M(+10.6%) |
| Sep 2023 | - | $29.20M(+3.2%) | $100.20M(+10.7%) |
| Jun 2023 | - | $28.29M(+23.7%) | $90.49M(+8.5%) |
| Mar 2023 | - | $22.87M(+15.3%) | $83.40M(+2.2%) |
| Dec 2022 | $81.60M | $19.84M(+1.8%) | $81.60M(+0.8%) |
| Sep 2022 | - | $19.49M(-8.1%) | $80.96M(+4.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $21.20M(+0.6%) | $77.16M(+10.5%) |
| Mar 2022 | - | $21.07M(+9.8%) | $69.82M(+21.0%) |
| Dec 2021 | $57.68M(+128.4%) | $19.20M(+22.4%) | $57.68M(+25.2%) |
| Sep 2021 | - | $15.69M(+13.3%) | $46.05M(+23.4%) |
| Jun 2021 | - | $13.85M(+55.0%) | $37.33M(+30.4%) |
| Mar 2021 | - | $8.94M(+18.0%) | $28.63M(+13.4%) |
| Dec 2020 | $25.26M(+33.3%) | - | - |
| Dec 2020 | - | $7.57M(+8.8%) | $25.26M(+42.8%) |
| Sep 2020 | - | $6.96M(+35.0%) | $17.68M(+65.0%) |
| Jun 2020 | - | $5.16M(-7.2%) | $10.72M(+92.8%) |
| Mar 2020 | - | $5.56M | $5.56M |
| Dec 2019 | $18.95M | - | - |
FAQ
- What is Recursion Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual SGA year-on-year change?
- What is Recursion Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly SGA year-on-year change?
- What is Recursion Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals TTM SGA year-on-year change?
What is Recursion Pharmaceuticals annual SGA?
The current annual SGA of RXRX is $178.18M
What is the all time high annual SGA for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual SGA is $178.18M
What is Recursion Pharmaceuticals annual SGA year-on-year change?
Over the past year, RXRX annual SGA has changed by +$67.36M (+60.78%)
What is Recursion Pharmaceuticals quarterly SGA?
The current quarterly SGA of RXRX is $54.65M
What is the all time high quarterly SGA for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly SGA is $77.19M
What is Recursion Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, RXRX quarterly SGA has changed by +$23.24M (+74.00%)
What is Recursion Pharmaceuticals TTM SGA?
The current TTM SGA of RXRX is -$5.47B
What is the all time high TTM SGA for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high TTM SGA is -$213.60M
What is Recursion Pharmaceuticals TTM SGA year-on-year change?
Over the past year, RXRX TTM SGA has changed by -$5.59B (-4686.23%)